Ares Capital Prices $750 Million Notes Offering Due 2031

Ares Capital Corporation, a leading global alternative asset manager, has priced a $750 million notes offering due 2031. The offering is part of Ares Capital's ongoing efforts to diversify its funding sources and reduce its reliance on traditional bank financing.

The notes will be issued under Ares Capital's existing shelf registration statement filed with the Securities and Exchange Commission (SEC). The offering is expected to close on January 8, 2026, subject to customary closing conditions.

Ares Capital has a strong track record of issuing debt securities, with over $10 billion in outstanding notes. The company's ability to access the debt capital markets has been a key factor in its growth and success.

The $750 million notes offering due 2031 is a significant milestone for Ares Capital, demonstrating the company's commitment to diversifying its funding sources and reducing its reliance on traditional bank financing.

Key Details:

• $750 million notes offering due 2031
• Issued under Ares Capital's existing shelf registration statement
• Expected to close on January 8, 2026, subject to customary closing conditions
• Part of Ares Capital's ongoing efforts to diversify its funding sources and reduce its reliance on traditional bank financing

Sources

[1] Ares Capital prices $750 million notes offering due 2031
[2] Form 144 Castle Biosciences For: 5 January
[3] Venezuela’s oil industry needs rebuilding. These U.S. companies will do it.